miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma

Tumor Biology

Volumn 37, Issue 12, 2016, Pages 15615-15625

  Lu, Wei ^a   Zhang, Yijian ^a,b   Zhou, Linzhu ^a   Wang, Xuan ^b   Mu, Jiasheng ^a   Jiang, Lin ^a,b   Hu, Yunping ^a,b   Dong, Ping ^a   Liu, Yingbin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gallbladder carcinoma; Malignant; miR 122; PKM2

Indexed keywords

MICRORNA 122; PYRUVATE KINASE; PYRUVATE KINASE M2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER INHIBITION; CELL FUNCTION; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GALLBLADDER CARCINOMA; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; METASTASIS; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFTWARE; UPREGULATION; WESTERN BLOTTING; WOUND HEALING MIGRATION ASSAY;

EID: 84946780537     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4308-z     Document Type: Article

References (32)

1. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109.
2. Rakic M, Patrlj L, Kopljar M, Klicek R, Kolovrat M, Loncar B, et al. Gallbladder cancer. Hepatobiliary Surg Nutr. 2014;3:221–6.
3. Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19:1912–38.
4. Yi B, Piazza GA, Su X, Xi Y. MicroRNA and cancer chemoprevention. Cancer Prev Res. 2013;6:401–9.
5. Fang YX, Gao WQ. Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene. 2014;33:135–47.
6. Li L, Xiao B, Tong H, Xie F, Zhang Z, Xiao GG. Regulation of breast cancer tumorigenesis and metastasis by miRNAs. Expert Rev Proteome. 2012;9:615–25.
7. Mannoor K, Liao J, Jiang F. Small nucleolar RNAs in cancer. Biochim Biophys Acta. 1826;2012:121–8.
8. Cherni I, Weiss GJ. MiRNAs in lung cancer: large roles for small players. Future Oncol. 2011;7:1045–55.
9. Liu C, Tang DG. MicroRNA regulation of cancer stem cells. Cancer Res. 2011;71:5950–4.
10. Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014;49:589–93.
11. Li Y, Masaki T, Lemon SM. Mir-122 and the hepatitis C RNA genome: more than just stability. RNA Biol. 2013;10:919–23.
12. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, et al. Mir-122, a mammalian liver-specific microRNA, is processed from HCR MRNA and may downregulate the high affinity cationic amino acid transporter cat-1. RNA Biol. 2004;1:106–13.
13. Chen CL, Wu JC, Chen GY, Yuan PH, Tseng YW, Li KC, et al. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. Mol Ther: J Am Soc Gene Ther. 2015;23:79–88.
14. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, et al. Cyclin g1 is a target of mir-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007;67:6092–9.
15. Wang B, Wang H, Yang Z. Mir-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS ONE. 2012;7, e47053.
16. Wang G, Zhao Y, Zheng Y. Mir-122/wnt/beta-catenin regulatory circuitry sustains glioma progression. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2014;35:8565–72.
17. Chen YJ, Chang LS. Hydroquinone-induced mir-122 down-regulation elicits adam17 up-regulation, leading to increased soluble TNF-alpha production in human leukemia cells with expressed bcr/abl. Biochem Pharmacol. 2013;86:620–31.
18. Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of mir-122 in liver. J Clin Invest. 2012;122:2871–83.
19. Kitamura T, Connolly K, Ruffino L, Ajiki T, Lueckgen A, DiGiovanni J, et al. The therapeutic effect of histone deacetylase inhibitor pci-24781 on gallbladder carcinoma in bk5.Erbb2 mice. J Hepatol. 2012;57:84–91.
20. Wong N, De Melo J, Tang D. PKM2, a central point of regulation in cancer metabolism. Int J Cell Biol. 2013;2013:242513.
21. Yang W, Lu Z. Nuclear PKM2 regulates the Warburg effect. Cell Cycle. 2013;12:3154–8.
22. Kwon OH, Kang TW, Kim JH, Kim M, Noh SM, Song KS, et al. Pyruvate kinase m2 promotes the growth of gastric cancer cells via regulation of bcl-xl expression at transcriptional level. Biochem Biophys Res Commun. 2012;423:38–44.
23. Li W, Xu Z, Hong J, Xu Y. Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival. Med Oncol. 2014;31:118.
24. Nemazanyy I, Espeillac C, Pende M, Panasyuk G. Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression. Biochem Soc Trans. 2013;41:917–22.
25. Kaboli PJ, Rahmat A, Ismail P, Ling KH. MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacol Res: Off J Ital Pharmacol Soc. 2015;97:104–21.
26. Zhou JJ, Zheng S, Sun LF, Zheng L. MicroRNA regulation network in colorectal cancer metastasis. World J Biol Chem. 2014;5:301–7.
27. Rothschild SI. MicroRNA therapies in cancer. Mol Cell Ther. 2014;2:7.
28. Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang Y, et al. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells. Int J Cancer J Int cancer. 2014;135:1019–27.
29. Dong Y, Yu J, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res. 2014;6:405–22.
30. Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, et al. MicroRNA in cervical cancer: oncomirs and tumor suppressor miRs in diagnosis and treatment. TheScientificWorldJOURNAL. 2014;2014:178075.
31. Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, et al. Mir-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. PLoS ONE. 2014;9, e86872.
32. Jung CJ, Iyengar S, Blahnik KR, Ajuha TP, Jiang JX, Farnham PJ, et al. Epigenetic modulation of mir-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS ONE. 2011;6, e27740.